Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.
about
A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma.Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysisPhase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma.Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells.Low prevalence of human papillomavirus in oral cavity squamous cell carcinoma in Queensland, Australia.Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinomanab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma.Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinomaPrognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma
P2860
Q34379240-6F98E927-1FFC-4486-A2CA-3221CC61E07FQ35133444-F2F071AD-A876-4629-AE3C-D8C285BE5CC6Q37304652-2A1AAB10-EE2D-4FE2-BC18-17919F5CAD48Q38291222-D0C40F2F-1864-4E64-AA2B-42588B00280AQ38693943-694E717C-93B5-4A87-A777-F0307080A756Q39841268-05EE5271-6F95-437C-8055-915C7BA2000CQ40514940-188992FE-CFB1-4F02-AC1A-4BF8E75334D9Q40559372-919D6D7C-77C0-44BE-A845-D7A4BFE7D02FQ42210776-7C129723-399D-4655-9B23-16A4731E441BQ46063070-9C458D13-ABA7-4AE3-B075-B873C3D46D8AQ49765539-152963E4-855A-417F-BFFD-EC062CCE70B7Q58694652-A1924406-2FF6-4783-AE87-2E0565B55990Q58761788-E67FCC6C-ADA2-4E47-AF88-4D5B2685A9F3
P2860
Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@en
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@nl
type
label
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@en
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@nl
prefLabel
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@en
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@nl
P2093
P2860
P1433
P1476
Cyclin D1-a prognostic marker ...... k human papillomavirus status.
@en
P2093
James S Lewis
Jingqin Luo
Juliette B Scantlebury
Samir K El-Mofty
Wade L Thorstad
P2860
P304
P356
10.1016/J.HUMPATH.2013.01.021
P407
P577
2013-04-06T00:00:00Z